Clinical Evaluation of a New Transpulmonary Thermodilution Method to Assess Thermodilution Cardiac Output, Global End Diastolic Volume and Extravascular Lung Water
1 other identifier
observational
97
2 countries
4
Brief Summary
The primary objective of this study is to obtain the TPTD, GEDV and EVLW measurements from existing indwelling femoral arterial Volume View™ catheter and central venous catheters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2010
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 20, 2011
CompletedFirst Posted
Study publicly available on registry
July 29, 2011
CompletedApril 4, 2013
April 1, 2013
11 months
July 20, 2011
April 1, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
TPTD, GEDV and EVLW measurements to evaluate the precision and accuracy of a novel algorithm in comparison to the widely accepted TPTD method
This is not an outcome study. This is an observational Study to obtain TPTD, GEDV and EVLW data to evaluate the precision and accuracy of a novel algorithm in comparison to the widely accepted TPTD method using an approach defined by Bland-Altman.
Up to 72 hours of femoral arterial catheter dwell time.
Study Arms (1)
EV1000 Observational Group
Patient must have an indwelling femoral arterial catheter and central venous catheter considered necessary for routine clinical monitoring; Patient, or legal guardian, will give consent prior to study enrollment and data capture; Patient must be at least 18 years old; Patient height and weight are available prior to study.
Eligibility Criteria
The study population will include all ICU patients requiring cardiac preload and lung water assessment.
You may qualify if:
- Patient must have clinical need for an indwelling femoral arterial catheter and central venous catheter.
- Patient, or legal guardian, must sign consent to be in the study prior to data capture.
- Patient must be at least 18 years old.
- Patient height and weight are available prior to study.
You may not qualify if:
- Patients with significant aortic valve regurgitation.
- Patients being treated with an intra-aortic balloon pump.
- Patients less than 40 kg in weight.
- Female patients with a known pregnancy or planned pregnancy.
- Patient is currently participating in an investigational drug or another device study that clinically interferes with the study endpoints.
- Patients with peripheral vascular disease.
- Patients with aortic aneurysm.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Universitätsklinikum der RWTH Aachen
Aachen, Pauwelsstrasse 30, 52074, Germany
Der Rheinischen Friedrich-Wilhelms-Universität Bonn
Bonn, Sigmund Freud Strasse 25, 53105, Germany
Stadtspital Triemli Zürich
Zurich, Birmensdorferstr 497, 8063, Switzerland
HUG-Hôpitaux Universitalres de Genève
Geneva, Canton of Geneva, 1211, Switzerland
Related Publications (2)
Bendjelid K, Marx G, Kiefer N, Simon TP, Geisen M, Hoeft A, Siegenthaler N, Hofer CK. Performance of a new pulse contour method for continuous cardiac output monitoring: validation in critically ill patients. Br J Anaesth. 2013 Oct;111(4):573-9. doi: 10.1093/bja/aet116. Epub 2013 Apr 26.
PMID: 23625132DERIVEDKiefer N, Hofer CK, Marx G, Geisen M, Giraud R, Siegenthaler N, Hoeft A, Bendjelid K, Rex S. Clinical validation of a new thermodilution system for the assessment of cardiac output and volumetric parameters. Crit Care. 2012 May 30;16(3):R98. doi: 10.1186/cc11366.
PMID: 22647561DERIVED
Study Officials
- STUDY DIRECTOR
Dana Deyette, RN, CCRP
Edwards Lifesciences LLC
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2011
First Posted
July 29, 2011
Study Start
January 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
April 4, 2013
Record last verified: 2013-04